What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Sillem M, et al. Mol Hum Reprod. 1997 Dec;3(12):1101-5. doi: 10.1093/molehr/3.12.1101. Mol Hum Reprod. 1997. PMID: 9464855
.
Item in Clipboard